Ace Alzheimer Center Barcelona presents 5 scientific posters at the AAIC 2021
The experts from Ace Alzheimer Center Barcelona are once again present at the Alzheimer's Association International Conference 2021 (AAIC), which in this edition is held virtually between July 27 and 30.
During this week, our team of researchers will have the opportunity to present 5 scientific posters about the latest advances in genetics and early detection of Alzheimer's. The MOPEAD, GR@ACE, BIOFACE and FACEHBI projects, in which Ace Alzheimer Center Barcelona participates, will have their space in this year's edition.
With this new and broad participation in the AAIC, one of the most important forums in the field of dementias, Ace Alzheimer Center Barcelona is positioned as a model entity in our country in the field of the research of Alzheimer's and other dementias.
The largest scientific event in the field of dementias
The AAIC, organized by the prestigious North American entity Alzheimer's Association, is one of the annual conferences of international reference within the Alzheimer's and dementia sector.
Experts from more than 70 countries around the world meet each year at the AAIC. The congress serves as a platform to present the main advances in Alzheimer's research and other types of dementia.
This is the list of posters and presentations that the experts from Ace Alzheimer Center Barcelona present in this edition of the congress:
A polygenic risk score for mosaic loss of chromosome Y susceptibility is associated with higher risk of MCI to AD progression – Pablo Garcia
Meta-GWAS of amyloid burden endophenotypes combining PET and CSF results – Raquel Puerta
Brain structural changes in subjective cognitive decline: a whole brain surface-based analysis in the FACEHBI cohort – Silvia Alonso-Lana
BIOFACE: A prospective study of risk factors, cognition and biomarkers in a cohort of individuals with Early-onset Mild Cognitive Impairment – Ester Esteban
Clinical reporting following the quantification of cerebrospinal fluid biomarkersin Alzheimer's disease: an international overview – C. Delaby